Back
Edge
StocktwitsPolls

symbol logo$SLS is down over 10% today but is still up over 125% year-to-date. Are you buying the dip?

SELLAS Life Sciences ($SLS) is down over 10% today and well off its 52-week high of $15.88, as investors wait on final analysis of its Phase 3 REGAL trial in AML and Phase 2 data for SLS009 expected in the fourth quarter. Are you buying $SLS on the dip? Vote and explain your reasoning in the comments.
10
13

Price since post

Full Details
Top Replies
Expharmaguy
Bought some more. First, SLS is a 2 asset AML company, and nothing about the science or the probability of successful data readouts has changed. What happened this morning is due to REGAL fatigue(some retail gets tired of waiting), short sellers, options expirations. Typical ebb and flow that makes a few shekels for the day trader, but as an investor will adhere to my Buffetinian mode. Its Turtles that win races.
1
9
Idfkytm
4
Kostcoboi
wow symbol logo$SLS got it’s very own poll Bullish
AnUnwiseInvestor
picked up nine more shares.
3
Lifetime
POSSIBILITIES
obviously a raid so they don’t have to pay options at $11 and maybe even $10. We NEED some news
NEWBIGTECH
holding and buying more. Why would the fda allow unlimited dosing to the people if it didn't work?
5
Bretm50
Its actually up 260 plus percent onthe yearly chart.
2
Funk49R
If I bought in the 10's and 11's why wouldn't I buy in the 9's
5
shkspr
It Broke a major support level and triggered the sell. it's going down more if the company doesn't release any catalyst. 8$ and even 5$ are new targets.
ISimplyHaveNoIdea
I think the guy that runs stocktwits is a “gay” and no one gives a shit what his pole has to say. His abuse of this community has been legendary.

Advertisement|Remove ads.